当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 利润表

康泰医学

(300869)

  

流通市值:44.41亿  总市值:70.44亿
流通股本:2.53亿   总股本:4.02亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入217,549,459.94111,844,411.72479,805,174.09333,885,288.03
  营业收入217,549,459.94111,844,411.72479,805,174.09333,885,288.03
二、营业总成本192,423,187.8493,516,783.56467,672,298.13336,662,644.47
  营业成本86,114,414.2146,809,494243,022,612.99167,266,311.47
  税金及附加4,931,403.23,472,842.698,463,226.616,524,487.08
  销售费用42,412,618.7415,862,954.3588,527,030.156,438,909.91
  管理费用17,112,193.378,074,873.7540,822,155.4126,684,621.96
  研发费用46,481,133.5922,572,126.74105,156,379.1783,429,418.51
  财务费用-4,628,575.27-3,275,507.97-18,319,106.15-3,681,104.46
  其中:利息费用--35,299,989.3-
  其中:利息收入--48,539,438.67-
三、其他经营收益
  加:公允价值变动收益2,752,724.312,307,189.111,588,083.19916,579.69
  加:投资收益849,480.1664,115.0622,518,834.8115,360,687.14
  资产处置收益0-16,317.68166,241.78166,241.78
  资产减值损失(新)-16,022,591.5-6,870,205.28-109,445,716.65-8,762,780.34
  信用减值损失(新)107,054.65-4,771.71-1,820,714.08-1,186,588.14
  其他收益5,523,541.592,817,310.377,310,075.546,755,701.03
四、营业利润18,336,481.2517,224,948.03-67,550,319.4510,472,484.72
  加:营业外收入495,178.41189,886.31,627,737.341,376,087.09
  减:营业外支出338,919268,394.627,964,744.43690,120.83
五、利润总额18,492,740.6617,146,439.71-73,887,326.5411,158,450.98
  减:所得税费用1,555,167.49710,671.934,015,238.141,255,523.12
六、净利润16,937,573.1716,435,767.78-77,902,564.689,902,927.86
(一)按经营持续性分类
  持续经营净利润16,937,573.1716,435,767.78-77,902,564.689,902,927.86
(二)按所有权归属分类
  归属于母公司股东的净利润16,937,573.1716,435,767.78-77,902,564.689,902,927.86
  扣除非经常损益后的净利润12,453,493.1813,769,664.12-95,079,251.37-6,456,856.79
七、每股收益
  (一)基本每股收益0.040.04-0.190.02
  (二)稀释每股收益0.04--0.17-
八、其他综合收益125,719.53138,597.25396,628.48-713,854.79
  归属于母公司股东的其他综合收益125,719.53138,597.25396,628.48-713,854.79
九、综合收益总额17,063,292.716,574,365.03-77,505,936.29,189,073.07
  归属于母公司股东的综合收益总额17,063,292.716,574,365.03-77,505,936.29,189,073.07
公告日期2025-08-292025-04-292025-04-292024-10-28
审计意见(境内)标准无保留意见
TOP↑